433
Participants
Start Date
February 28, 2009
Primary Completion Date
November 30, 2009
Study Completion Date
November 30, 2009
repaglinide
The dose was started from repaglinide 1 mg plus metformin 500 mg once daily. During the dose titration period, the dose could be titrated up to repaglinide 4 mg and metformin 500mg three times daily, according to fasting glucose. the minimal dose was repaglinide 1 mg plus metformin 500 mg three times daily
metformin
The dose was started from repaglinide 1 mg plus metformin 500 mg once daily. During the dose titration period, the dose could be titrated up to repaglinide 4 mg and metformin 500 mg three times daily, according to fasting glucose. the minimal dose was repaglinide 1 mg plus metformin 500 mg three times daily
repaglinide
The dose was started from repaglinide 1 mg three times daily. During the dose titration period, the dose of repaglinide could be titrated up to 4 mg three times daily, according to fasting glucose.
Novo Nordisk Investigational Site, Shanghai
Novo Nordisk Investigational Site, Shanghai
Novo Nordisk Investigational Site, Shanghai
Novo Nordisk Investigational Site, Shanghai
Novo Nordisk Investigational Site, Shanghai
Novo Nordisk Investigational Site, Shanghai
Novo Nordisk Investigational Site, Nanjing
Novo Nordisk Investigational Site, Nanjing
Novo Nordisk Investigational Site, Nanjing
Novo Nordisk Investigational Site, Wuxi
Novo Nordisk Investigational Site, Suzhou
Novo Nordisk Investigational Site, Nantong
Novo Nordisk Investigational Site, Hangzhou
Novo Nordisk Investigational Site, Hangzhou
Novo Nordisk Investigational Site, Wenzhou
Novo Nordisk Investigational Site, Nanchang
Novo Nordisk Investigational Site, Fuzhou
Lead Sponsor
Novo Nordisk A/S
INDUSTRY